期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分子动力学研究抑制剂APV与HIV-1蛋白酶的作用机制 被引量：1

Molecular dynamics insights into binding mode of inhibitor APV to HIV-1 protease
下载PDF
导出
摘要 采用分子动力学模拟和结合自由能计算研究了抑制剂APV与HIV-1蛋白酶的作用机制.研究结果表明范德瓦尔斯作用主控了APV与HIV-1蛋白酶的结合.采用基于残基的自由能分解方法计算了抑制剂-残基相互作用,结果表明9个残基Gly27、Ile32、Val47、Ile50、Ile84、Ala28'、Gly49'、Ile50'和Arg87'与APV产生了大于1.0 kcal/mol的强相互作用,而且证明CH-π,CH-O相互作用和极性作用是其结合的主要形式.期待该结果可以为以HIV-1蛋白酶为靶标的抗艾滋病药物设计提供理论上的指导. Molecular dynamics simulation and binding free energy calculation was performed to study the binding mode of inhibitor APV to HIV - 1 protease. The results show that van der walls energy is the main force driving the binding of APV to HIV - 1 protease. Residue - based free energy decomposition was adopted to calculate the inhibitor- residue interaction and the results suggest that nine residues Gly27, Ile32, Va147, Ile50, Ile84, Ala28＇, Gly49＇, Ile50＇ and Arg87＇ in HIV - 1 protease produce strong interactions with APV, at the same time, these results also show that the CH - π, CH - O and polar interaction are the main ones between APV and HIV - 1 protease. We expect that this study can provide significant contributions to the designs of anti - AIDS targeting HIV - 1 protease.
作者 时术华 张少龙 张庆刚
机构地区 山东建筑大学理学院 山东师范大学物理与电子科学学院
出处 《原子与分子物理学报》 CAS CSCD 北大核心 2015年第5期885-890,共6页 Journal of Atomic and Molecular Physics
基金 国家自然科学基金(11274206) 山东省自然科学基金(ZR2011HM048 ZR2013AM014) 山东建筑大学博士启动基金(XNBS1268)
关键词 分子动力学 结合自由能 HIV-1蛋白酶 MM-PBSA Molecular dynamics Binding free energy HIV- 1 protease MM- PBSA
分类号 Q641.12 [生物学—生物物理学]
  • 相关文献

参考文献26

  • 1Judd D A, Nettles J H, Nevins N, et al. Polyoxometa- late HIV - 1 protease inhibitors. A new mode of prote- ase inhibition [J]. J. Am. Chem. Soc. , 2001, 123: 886.
  • 2Tie Y, Wang Y F, Boross P I, et al. Critical differ-ences in HIV - 1 and HIV - 2 protease specificity for clinical inhibitors[J]. Protein Science, 2012, 21 : 339.
  • 3Blum A, BSttcher J, Heine A, et al. Structure - guided design of C 2 - symmetric HIV - 1 protease in- hibitors based on a pyrrolidine scaffold? [J]. J. Med. Chem. , 2008, 51: 2078.
  • 4Brik A, Wong C H. HIV - 1 protease: mechanism and drug discovery [J]. Org. Biomol. Chem. , 2003, 1 : 5.
  • 5PerrymanA L, Lin J H, McCammon J A. HIV - 1 protease molecular dynamics of a wild - type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs [J]. Protein Science, 2009, 13: 1108.
  • 6Soriano V, Gomes P, Heneine W, et al. Human im- munodeficieney virus type 2 ( HIV - 2 ) in Portugal: Clinical spectrum, circulating subtypes, virus isola- tion, and plasma viral load [ J]. J. Med. Virol., 2000, 61: 111.
  • 7Shen C H, Wang Y F, Kovalevsky A Y, et al. Am- prenavir complexes with HIV - 1 protease and its drug resistant mutants altering hydrophobic clusters [J]. FEB& J. , 2010, 277: 3699.
  • 8Tie Y, Wang Y F, Boross P I, et al. Critical differ- ences in HIV - 1 and HIV - 2 protease specificity for clinical inhibitors [J]. Protein Science, 2012, 21: 339.
  • 9Chen J, Wang J, Zhu W, et al. A computational anal- ysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings [ J]. J. Comput. Aided Mol. Des. , 2013, 27: 965.
  • 10Wu E L, Han K L, Zhang J Z H. Selectivity of neu- tral/weakly basic PI group inhibitors of thrombin and trypsin by a molecular dynamics study[J].Chemistry - A European Journal, 2008, 14: 8704.

二级参考文献51

  • 1蒋勇军,曾敏,周先波,邹建卫,俞庆森.CDK2-抑制剂结合自由能计算[J].化学学报,2004,62(18):1751-1754. 被引量：11
  • 2胡建平,孙庭广,陈慰祖,王存新.谷氨酰胺结合蛋白的分子动力学模拟和自由能计算[J].化学学报,2006,64(20):2079-2085. 被引量：12
  • 3Renaud J P,Moras D.Structural studies on nuclear receptors[J].Cell.Mol.Life.Sci.,2000,57:1748.
  • 4Pasqualini J R,Paris J,Sitruk-Ware R,et al.Progestins and breast cancer[J].J.Steroid.Biochem.Mo.l Biol.,1998,65:225.
  • 5Jin H X,Wu T X,Jiang Y J,et al.Functional role of three water molecules buried within catalytic subunit of cyclic 30,50-adenosine monophosphate-dependent protein kinase[J].J.Mol.Struct.(Theochem),2007,809:21.
  • 6Hu G D,Zhu T,Zhang S L,Wang D,et al.Some insights into mechanism for binding and drug resistance of wild type and I50V V82A and I84V mutations in HIV-1 protease with GRL-98065 inhibitor from molecular dynamic simulations[J].Eur.J.Med.Chem.,2010,45:227.
  • 7Xu Y,Wang R X.A computational analysis of the binding affinities of FKBP12 inhibitors using the MM-PB/SA method[J].Proteins.,2006,64:1058.
  • 8Williams S P,Sigler P B.Atomic structure of progesterone complexed with its receptor[J].Nature,1998,393:392.
  • 9Case D A,Darden T A,Cheatham II T E,et al.2006,AMBER 9,University of California,San Francisco.
  • 10Kollman P A,Massova I,Reyes C,et al.Calculating structures and free energies of complex molecules:combining molecular mechanics and continuum models[J].Acc.Chem.Res.,2000,33:889.

共引文献13

同被引文献20

  • 1Egelrud T, Brattsand M, Kreutzmann P, et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6 [ J ]. Bright. J. Dermatol. , 2005, 153: 1200.
  • 2Mitsudo K, Jayakumar A, Henderson Y, et al. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis [ J]. Biochemistry, 2003, 42 : 3874.
  • 3Yamane J, Yao M, Zhou Y, et al. In -crystal affinity ranking of fragment hit compounds reveals a relationship with their inhibitory activities [ J ]. J. Appl. Crystallog. , 2011,44 : 798.
  • 4Liebschner D, Dauter M, Brzuszkiewicz A, et al. On the reproducibility of protein crystal structures: five atomic resolution structures of trypsin [ J ] . Acta Crystallog. D: Biolog. Crystallog., 2013, 69: 1447.
  • 5Zhang H M, Wang Y Q, Zhou Q H. Investigation of the interactions of quercetin and morin with trypsin[J]. Luminescence, 2009, 24: 355.
  • 6Chen J, Wang J, Zhang Q, et al. A comparative study of trypsin specificity based on QM/MM molecular dynamics simulation and QM/MM GBSA calculation [J]. J. Biomol. Stuct. Dyn. , 2015: DOI:10. 1080/ 07391102. 2014. 1003146.
  • 7Chen J, Liang Z, Wang W, et al. Revealing origin of decrease in potency of darunavir and amprenavir against HIV -2 relative to HIV -1 protease by molecular dynamics simulations [J]. Sci. Rep. , 2014, 4: 6872.
  • 8Zhu T, Xiao X, Ji C, et al. A new quantum calibrated force field for zinc - protein complex [ J ]. J. Chem. Theory Comput. , 2013, 9:1788.
  • 9Wang J, Yang H, Zuo Z, et al. Molecular dynamics simulations on the mechanism of transporting methylamine and ammonia by ammonium transporter A mt B [ J ]. J. Phys. Chem. B, 2010, 114: 15172.
  • 10Wu E L, Mei Y, Han K L, et al. Quantum andmolecular dynamics study for binding of macrocyclic inhibitors to human [ alpha] -thrombin [ J]. Biophys. J, 2007, 92: 4244.

引证文献1

二级引证文献2

原子与分子物理学报
2015年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部